What is Cytokinetics's accrued liabilities?

Cytokinetics (CYTK) reported accrued liabilities of -$6.21M in Q1 2026.

How has Cytokinetics's accrued liabilities changed year-over-year?

Cytokinetics's accrued liabilities increased by 56.8% year-over-year, from -$14.37M to -$6.21M.

What is the long-term trend for Cytokinetics's accrued liabilities?

Over 4 years (2021 to 2025), Cytokinetics's accrued liabilities has grown at a 22.2% compound annual growth rate (CAGR), from $15.06M to $33.6M.

Cytokinetics CYTK Accrued liabilities

Accrued liabilities at other companies

Unity SoftwareU

$13.96M+166%

NRG EnergyNRG

-$315M-70.3%

Baxter InternationalBAX

$203M+42.0%

Zoom Video Communications, Inc.ZM

$533.19M+12.5%

Edwards LifesciencesEW

$1.2B+0.6%

PopularBPOP

——

Other financials

Income statement

See full

Revenue$19.4M+1,126%

Operating income-$183.6M-18.0%

Net income-$206.0M-27.7%

EPS (diluted)-$1.67-22.8%

Balance sheet

See full

Cash & equivalents$129.8M+76.2%

Total debt$418.2M+75.8%

Total equity-$826.6M-210%

Total assets$1.3B+0.7%

Cash flow

See full

Operating cash flow-$145.5M-10.5%

CapEx$5.9M+4.7%

Free cash flow-$151.4M-10.3%

Valuation

See full

Market cap$10.7B+70.6%

Enterprise value$10.98B+70.7%

P/S101.1×-225×

Profitability

See full

Operating margin-605.1%-268pp

Net margin-784%-337pp

FCF margin-518.8%-223pp

Returns & leverage

See full

Return on equity-337.6%—

Debt / equity2.2×—

Current ratio4.2×-1.8×

Where this comes from

Reported directly by Cytokinetics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytokinetics's accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytokinetics's accrued liabilities?: Cytokinetics (CYTK) reported accrued liabilities of -$6.21M in Q1 2026.
How has Cytokinetics's accrued liabilities changed year-over-year?: Cytokinetics's accrued liabilities increased by 56.8% year-over-year, from -$14.37M to -$6.21M.
What is the long-term trend for Cytokinetics's accrued liabilities?: Over 4 years (2021 to 2025), Cytokinetics's accrued liabilities has grown at a 22.2% compound annual growth rate (CAGR), from $15.06M to $33.6M.